Loading publications…
The last 5 uploaded publications
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer
Josep M. Llovet, Michel Ducreux, Riccardo Lencioni, Adrian M. Di Bisceglie, Jean‐François Dufour, Tim F. Greten, Éric Raymond, Tania Roskams, Vincenzo Mazzaferro, Jordi Bruix, Massimo Colombo, Andrew X. Zhu (2012). EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer.
Article145 days agoThe management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Michel Ducreux, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab, Jordan Berlin, Andrés Cervantes, Thierry de Baère, Charis Eng, Peter R. Galle, Sharlene Gill, Thomas Gruenberger, Karin Haustermans, Ángela Lamarca, Pierre Laurent‐Puig, Josep M. Llovet, F. Lordick, Teresa Macarulla, Deborah Mukherji, Kei Muro, Radka Obermannová, Juan Manuel O’Connor, Eileen M. O’Reilly, Pia Österlund, P. A. Philip, G. Prager, Érika Ruiz-García, Bruno Sangro, Thomas Seufferlein, Josep Tabernero, Chris Verslype, Harpreet Wasan, Eric Van Cutsem (2023). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO Open, 8(3), pp. 101567-101567, DOI: 10.1016/j.esmoop.2023.101567.
Article145 days agoHepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Arndt Vogel, S.L. Chan, Laura A. Dawson, R.K. Kelley, Josep M. Llovet, Tim Meyer, Jens Ricke, Lorenza Rimassa, Gonzalo Sapisochín, Valérie Vilgrain, Jessica Zucman‐Rossi, Michel Ducreux (2025). Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, DOI: 10.1016/j.annonc.2025.02.006.
Article145 days agoChemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Erika Vacchelli, Yuting Ma, Elisa Elena Baracco, Antonella Sistigu, David Enot, Federico Pietrocola, Heng Yang, Sandy Adjemian, Kariman Chaba, Michaëla Semeraro, Michele Signore, Adele De Ninno, Valeria Lucarini, Francesca Peschiaroli, Luca Businaro, Annamaria Gerardino, Gwenola Manic, Thomas Ulas, Patrick Günther, Joachim L. Schultze, Oliver Kepp, Gautier Stoll, Céline Lefèbvre, Claire Mulot, Francesca Castoldi, Sylvie Rusakiewicz, Sylvain Ladoire, Lionel Apétoh, José Manuel Bravo‐San Pedro, Monica Lucattelli, Cécile Delarasse, Valérie Boige, Michel Ducreux, Suzette Delaloge, Christophe Borg, Fabrice André, Giovanna Schiavoni, Ilio Vitale, Pierre Laurent‐Puig, Fabrizio Mattei, Laurence Zitvogel, Guido Guido Kroemer (2015). Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. , 350(6263), DOI: https://doi.org/10.1126/science.aad0779.
Article73 days agoImmunogenic death of colon cancer cells treated with oxaliplatin
Antoine Tesnière, F. Schlemmer, Valérie Boige, Oliver Kepp, Isabelle Martins, François Ghiringhelli, Laetitia Aymeric, Michael Michaud, Lionel Apétoh, Ludovic Barault, Jean Mendiboure, Jean‐Pierre Pignon, Valérie Jooste, Peter Van Endert, Michel Ducreux, Laurence Zitvogel, F Piard, Guido Guido Kroemer (2009). Immunogenic death of colon cancer cells treated with oxaliplatin. , 29(4), DOI: https://doi.org/10.1038/onc.2009.356.
Article73 days ago